Premier Biomedical, Inc. (BIEI)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Oct 30, 2024, 4:00 PM EDT
Premier Biomedical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '19 Dec 31, 2019 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2014 - 2010 |
| Revenue | 0.01 | 0.01 | 0.04 | 0.04 | - | - | Upgrade
|
| Revenue Growth (YoY) | -64.11% | -64.11% | 0.09% | - | - | - | Upgrade
|
| Cost of Revenue | 0.01 | 0.01 | 0.11 | 0.03 | - | - | Upgrade
|
| Gross Profit | 0 | 0 | -0.07 | 0.01 | - | - | Upgrade
|
| Selling, General & Admin | 0.33 | 0.33 | 0.62 | 1.12 | 0.52 | 2.15 | Upgrade
|
| Research & Development | - | - | - | 0.18 | 0.11 | 0.23 | Upgrade
|
| Operating Expenses | 0.33 | 0.33 | 0.62 | 1.3 | 0.64 | 2.38 | Upgrade
|
| Operating Income | -0.33 | -0.33 | -0.69 | -1.29 | -0.64 | -2.38 | Upgrade
|
| Interest Expense | -0.39 | -0.39 | -0.42 | -0.35 | -0.82 | -0.2 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.34 | 0.34 | 0.7 | -2.12 | -0.37 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | -0.37 | -0.37 | -0.41 | -3.76 | -1.82 | -2.6 | Upgrade
|
| Other Unusual Items | - | - | 0.01 | - | 0.05 | - | Upgrade
|
| Pretax Income | -0.37 | -0.37 | -0.4 | -3.76 | -1.77 | -2.6 | Upgrade
|
| Net Income | -0.37 | -0.37 | -0.4 | -3.76 | -1.77 | -2.6 | Upgrade
|
| Net Income to Common | -0.37 | -0.37 | -0.4 | -3.76 | -1.77 | -2.6 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 52 | 4 | 2 | 1 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 52 | 4 | 2 | 1 | 0 | Upgrade
|
| Shares Change (YoY) | 1394.89% | 1394.89% | 78.96% | 222.90% | 385.06% | 53.19% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.11 | -1.92 | -2.91 | -20.80 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.11 | -1.92 | -2.91 | -20.80 | Upgrade
|
| Free Cash Flow | -0.35 | -0.35 | -0.45 | -0.51 | -0.49 | -0.46 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.13 | -0.26 | -0.80 | -3.70 | Upgrade
|
| Gross Margin | 9.95% | 9.95% | -185.78% | 36.02% | - | - | Upgrade
|
| Operating Margin | -2287.90% | -2287.90% | -1741.03% | -3243.98% | - | - | Upgrade
|
| Profit Margin | -2622.16% | -2622.16% | -1002.35% | -9465.45% | - | - | Upgrade
|
| Free Cash Flow Margin | -2444.02% | -2444.02% | -1123.02% | -1282.19% | - | - | Upgrade
|
| EBITDA | -0.32 | -0.32 | -0.69 | -1.29 | -0.64 | -2.38 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| EBIT | -0.33 | -0.33 | -0.69 | -1.29 | -0.64 | -2.38 | Upgrade
|
| Advertising Expenses | 0.05 | 0.05 | 0.07 | 0.06 | 0.08 | 0.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.